Home524606 • BOM
add
Beryl Drugs Ltd
Previous close
₹19.50
Day range
₹19.30 - ₹20.47
Year range
₹17.35 - ₹46.00
Market cap
98.64M INR
Avg Volume
1.84K
P/E ratio
17.06
Dividend yield
-
Primary exchange
BOM
Market news
CDRO
2.48%
1.92%
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 39.74M | 33.54% |
Operating expense | 9.76M | 761.36% |
Net income | 1.52M | 143.75% |
Net profit margin | 3.82 | 132.73% |
Earnings per share | — | — |
EBITDA | 4.92M | 2,760.54% |
Effective tax rate | -49.07% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.14M | 265.04% |
Total assets | 159.60M | -8.73% |
Total liabilities | 64.56M | -24.61% |
Total equity | 95.04M | — |
Shares outstanding | 5.06M | — |
Price to book | 1.04 | — |
Return on assets | — | — |
Return on capital | 3.30% | — |
Cash Flow
Net change in cash
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 1.52M | 143.75% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1993
Website